Cancer: crossing over to drug resistance.
Livingston
David M
DM
Silver
Daniel P
DP
D000970:Antineoplastic Agents / Q000494:pharmacology*; D024682:BRCA2 Protein / Q000172:deficiency / Q000235:genetics; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics*; D053960:DNA Breaks; D019008:Drug Resistance, Neoplasm / Q000187:drug effects / Q000235:genetics*; D005260:Female; D024522:Genes, BRCA2; D006801:Humans; D009154:Mutation / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000235:genetics*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011995:Recombination, Genetic / Q000235:genetics*
D000970:Antineoplastic Agents; D024682:BRCA2 Protein; D000067856:Poly(ADP-ribose) Polymerase Inhibitors